• Home
  • News
  • Fortune 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia

UrgentRx is reinventing pills

By
Matt Vella
Matt Vella
Down Arrow Button Icon
By
Matt Vella
Matt Vella
Down Arrow Button Icon
March 20, 2013, 11:21 AM ET

By Doron Levin, contributor

FORTUNE — Jordan Eisenberg, 31, was carrying a Benadryl around in his wallet back in 2009 when it dawned on him that he should find a better way to ensure his own safety in case of an allergy attack. He’s violently allergic to carrots, peanuts and many other fresh fruits and vegetables. “It’s unsanitary, the pills fall out and they disintegrate,” says Eisenberg, the chief executive officer of UrgentRx, his Denver, Colorado-based startup. His father and friends also carried aspirin in their wallets in the event of a heart attack.

His solution? Flavored powder in a credit card-sized, moisture-proof envelope. The powder comes close to emulating the taste of candy products like Pixy Stix. Creating a fruit-flavored powder that could deliver common over-the-counter medicines such as aspirin, calcium carbonate (for upset stomach) and diphenyldramine HCl (for allergy attacks) “wasn’t easy,” Eisenberg said. “Our drugs aren’t candy, it’s really hard to mask the taste of medicine through micro-encapsulation.”

Following its launch in January, UrgentRx powders have been sold in 3,000 stores nationwide. The goal is to get them into 25,000 stores, including such major chains as CVS (CVS). Each packet sells for a suggested retail price of $1.39.

MORE: Nobody needs an Apple iWatch—or anything like it

Eisenberg, a double major in engineering and mathematics from Vanderbilt University, originally worked as an investment banker before taking a job with the noted inventor and patent-holder, Maurice Kanbar. Kanbar created Skyy Vodka and other well-known products. “I always thought I wanted to be a venture capitalist,” says Eisenberg. “I came to understand that entrepreneurship is a rare commodity, it’s what I was meant to do.”

In the process of trying to raise investment capital, a mutual acquaintance introduced him to Randall Kaplan, a Los Angeles-based entrepreneur and investor who was a co-founder of Akamai Technologies (AKAM).

UrgentRx, with $5 million in funding, two years ago had a limited rollout to pharmacy chains and other retailers that sell remedies. “We made packaging and other changes,” Eisenberg said. “The feedback was incredibly important.” The company, which has eight employees, has just hired two vice presidents, one for sales and one for marketing.

MORE: How Rackspace is taking on Amazon now

Eisenberg’s hook is the claim that the company’s powdered aspirin, which it says acts faster than pills, has saved at least ten lives of people who swallowed UrgentRx when they were having a heart attack. Another plus, he says, is that the product is ideal for the estimated 6% of the population that is unable or has difficulty swallowing pills.

After investing in UrgentRx and becoming the company’s chairman, Kaplan is helping to raise another $2.5 million, which will be used in part to finance the marketing of the powders to more retailers. New investors include Sam Zell, the Chicago financier, actress Hillary Swank and Herb Simon, the shopping mall magnate.

UrgentRx follows on the heels of innovative delivery systems for medicinal products and caffeine, such as Vitamin Water and 5-Hour Energy Drink. The investors are hoping the packets will become a staple of home medicine cabinets—much like Alka Seltzer in the 1940s.

About the Author
By Matt Vella
See full bioRight Arrow Button Icon

Latest in

CryptoBinance
Binance has been proudly nomadic for years. A new announcement suggests it’s finally chosen a headquarters
By Ben WeissDecember 7, 2025
3 hours ago
Big TechStreaming
Trump warns Netflix-Warner deal may pose antitrust ‘problem’
By Hadriana Lowenkron, Se Young Lee and BloombergDecember 7, 2025
7 hours ago
Big TechOpenAI
OpenAI goes from stock market savior to burden as AI risks mount
By Ryan Vlastelica and BloombergDecember 7, 2025
7 hours ago
InvestingStock
What bubble? Asset managers in risk-on mode stick with stocks
By Julien Ponthus, Natalia Kniazhevich, Abhishek Vishnoi and BloombergDecember 7, 2025
8 hours ago
EconomyTariffs and trade
Macron warns EU may hit China with tariffs over trade surplus
By James Regan and BloombergDecember 7, 2025
8 hours ago
EconomyTariffs and trade
U.S. trade chief says China has complied with terms of trade deals
By Hadriana Lowenkron and BloombergDecember 7, 2025
8 hours ago

Most Popular

placeholder alt text
Real Estate
The 'Great Housing Reset' is coming: Income growth will outpace home-price growth in 2026, Redfin forecasts
By Nino PaoliDecember 6, 2025
2 days ago
placeholder alt text
AI
Nvidia CEO says data centers take about 3 years to construct in the U.S., while in China 'they can build a hospital in a weekend'
By Nino PaoliDecember 6, 2025
2 days ago
placeholder alt text
Economy
The most likely solution to the U.S. debt crisis is severe austerity triggered by a fiscal calamity, former White House economic adviser says
By Jason MaDecember 6, 2025
1 day ago
placeholder alt text
Economy
JPMorgan CEO Jamie Dimon says Europe has a 'real problem’
By Katherine Chiglinsky and BloombergDecember 6, 2025
1 day ago
placeholder alt text
Big Tech
Mark Zuckerberg rebranded Facebook for the metaverse. Four years and $70 billion in losses later, he’s moving on
By Eva RoytburgDecember 5, 2025
3 days ago
placeholder alt text
Politics
Supreme Court to reconsider a 90-year-old unanimous ruling that limits presidential power on removing heads of independent agencies
By Mark Sherman and The Associated PressDecember 7, 2025
16 hours ago
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.